This article is a comment on the In re Ciprofloxacin Hydrochloride Antitrust Litigation which was filed prior to September 11, 2001, and the decision was rendered with the terrorist attacks still one month in the future. The suit was filed claiming an antitrust violation against Bayer...

This article regards the problem of access and affordability of drugs to impoverished consumers. The article first explores the Trade-Related Aspects of Intellectual Property Rights (TRIPS) consistent possibilities which balances the interests of the pharmaceutical companies and consumers, and...

Neil Averitt and Robert Lande have for some time been writing about consumer choice as a new paradigm for antitrust. In this comment, I both praise and extend the consumer choice paradigm and provide concrete examples of both cutting edge and familiar antitrust issues where consumer choice can...